Want to join the conversation?
$MRK said that with more than 200 clinical trials and more than 100 combinations in over 30 tumor types, the company is seeing the potential to drive significant growth for KEYTRUDA longer term. In 2016, $MRK will continue to prioritize resources, focusing on JANUVIA, hospital acute care, vaccines and product launches such as ZEPATIER and KEYTRUDA.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!